Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Cervical Adenosquamous Carcinoma”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Large-scale testing (Phase 3)Study completedNCT01365156
What this trial is testing

Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix

Who this might be right for
Cervical Squamous Cell CarcinomaAdenosquamous CarcinomaAdenocarcinoma+2 more
M.D. Anderson Cancer Center 28
Not applicableStudy completedNCT00895349
What this trial is testing

Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)

Who this might be right for
Cervical CancerSquamous Cell CarcinomaAdenosquamous Carcinoma+1 more
Ontario Clinical Oncology Group (OCOG) 171
Testing effectiveness (Phase 2)Study completedNCT00416455
What this trial is testing

Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical Small Cell Carcinoma+11 more
National Cancer Institute (NCI) 384
Testing effectiveness (Phase 2)Ended earlyNCT00570674
What this trial is testing

Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckBasaloid Squamous Cell CarcinomaUndifferentiated Carcinoma+1 more
Dana-Farber Cancer Institute 29
Early research (Phase 1)Active Not RecruitingNCT05973487
What this trial is testing

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more
TScan Therapeutics, Inc. 840
Not applicableStudy completedNCT00460356
What this trial is testing

Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+6 more
Gynecologic Oncology Group 159
Testing effectiveness (Phase 2)Study completedNCT01026792
What this trial is testing

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+5 more
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT00003017
What this trial is testing

Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix

Who this might be right for
Cervical Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Active Not RecruitingNCT02595879
What this trial is testing

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

Who this might be right for
Advanced Cervical AdenocarcinomaAdvanced Cervical Adenosquamous CarcinomaAdvanced Cervical Squamous Cell Carcinoma+10 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00369122
What this trial is testing

Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+4 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT03738228
What this trial is testing

Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+8 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00005070
What this trial is testing

Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00389974
What this trial is testing

Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical Squamous Cell Carcinoma+2 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00287911
What this trial is testing

Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Masonic Cancer Center, University of Minnesota 18
Testing effectiveness (Phase 2)UnknownNCT03469531
What this trial is testing

Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Who this might be right for
NeoplasmsCervical Adenosquamous Cell CarcinomaCervical Squamous Cell Carcinoma in Situ+5 more
Zhujiang Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00023660
What this trial is testing

Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Radiation Therapy Oncology Group 84
Testing effectiveness (Phase 2)Study completedNCT00276796
What this trial is testing

Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 66
Early research (Phase 1)Study completedNCT01281852
What this trial is testing

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+2 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06805864
What this trial is testing

Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous Carcinoma
Gunma University 45
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Load More Results